Stock LAURUSLABS LAURUS LABS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Laurus Labs Limited

Equities

LAURUSLABS

INE947Q01028

Pharmaceuticals

Delayed NSE India S.E.
Other stock markets
 07:42:30 2024-04-30 am EDT 		5-day change 1st Jan Change
450 INR +1.41% Intraday chart for Laurus Labs Limited +4.64% +4.60%
Apr. 25 Transcript : Laurus Labs Limited, Q4 2024 Earnings Call, Apr 25, 2024
Apr. 25 Laurus Labs Limited Approves Board Changes CI

Business Summary

Laurus Labs Limited is an India-based pharmaceutical and biotechnology company. The Company offers integrated portfolio of Active Pharma Ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services to cater to the needs of the global pharmaceutical industry. The Company operates through three segments: Laurus Generics, Laurus Synthesis, and Laurus Bio. The Laurus Generics segment comprises API and FDF-Development, manufacture and sale of APIs and advanced intermediates and oral solid formulations/FDF. Laurus Synthesis segment comprises key starting materials (KSM), intermediates and APIs for new chemical entities (NCEs). Laurus Bio segment comprises recombinant products, animal origin free products for safer and viral free bio manufacturing. The Company operates through two geographical segments: Revenue from customers within India-Domestic, and Revenue from customers outside India-Exports. The Company sell its APIs in 56 countries.

Number of employees: 5,753

Sales per Business

INR in Million2022Weight2023Weight Delta
Active Pharmaceutical Ingredients, Intermediates and Formulations
93.4 %
44,602 90.4 % 56,448 93.4 % +26.56%
Contract Research Services
3.4 %
2,423 4.9 % 2,065 3.4 % -14.79%
Traded Goods
2.7 %
1,861 3.8 % 1,629 2.7 % -12.45%
Others
0.2 %
390 0.8 % 143 0.2 % -63.33%
Scrap
0.2 %
76 0.2 % 118 0.2 % +54.86%
Export and Other Incentives
0.0 %
4 0.0 % 2 0.0 % -43.90%

Sales per region

INR in Million2022Weight2023Weight Delta
International
72.3 %
35,567 72.1 % 43,667 72.3 % +22.78%
India
27.7 %
13,789 27.9 % 16,738 27.7 % +21.39%

Managers

Managers TitleAgeSince
Satyanarayana Chava FOU
 Founder 63 05-09-18
Ravi Kumar V. Vantaram DFI
 Director of Finance/CFO - 06-11-29
S. Srinivasa Rao COO
 Chief Operating Officer - 08-04-01
V. Uma Maheswer Rao CTO
 Chief Tech/Sci/R&D Officer - 16-06-08
Venkateswar G. Reddy CMP
 Compliance Officer - 15-11-30
Anil Kumar Reddy Shamakura PRN
 Corporate Officer/Principal - -
Ch Sita Ramaiah PRN
 Corporate Officer/Principal - -
Narasimha Rao Chava HRO
 Human Resources Officer - -
Martyn Peck PRN
 Corporate Officer/Principal - 08-08-17

Members of the board

Members of the board TitleAgeSince
Satyanarayana Chava FOU
 Founder 63 05-09-18
Venugopala Rao Malempati CHM
 Chairman 83 17-05-23
Ravindranath Kancherla BRD
 Director/Board Member 68 -
Venkata Lakshmana R. Chunduru BRD
 Director/Board Member - 07-01-31
Ravi Kumar V. Vantaram DFI
 Director of Finance/CFO - 06-11-29
Aruna Rajendra Bhinge BRD
 Director/Board Member 66 16-07-06
Rajesh Koshy Chandy BRD
 Director/Board Member - 16-07-26

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 538,965,858 352,537,865 ( 65.41 %) 0 65.41 %

Shareholders

NameEquities%Valuation
The Innovation Group Ltd.
23.03 %
124,126,740 23.03 % 583 M ₹
Amansa Holdings Pvt Ltd.
4.047 %
21,814,627 4.047 % 102 M ₹
Anukar Projects Pvt Ltd.
3.244 %
17,483,605 3.244 % 82 M ₹
Mirae Asset Investment Managers (India) Pvt Ltd.
3.079 %
16,594,535 3.079 % 78 M ₹
Life Insurance Corporation of India (Investment Portfolio)
2.702 %
14,560,251 2.702 % 68 M ₹
Venkata Lakshmana R. Chunduru
2.496 %
13,450,145 2.496 % 63 M ₹
Barclays Wealth Trustees (India) Pvt Ltd.
1.354 %
7,295,378 1.354 % 34 M ₹
Akash Bhanshali
1.327 %
7,151,700 1.327 % 34 M ₹
SBI Funds Management Ltd.
0.6688 %
3,604,725 0.6688 % 17 M ₹
Franklin Templeton Asset Management (India) Pvt Ltd.
0.6535 %
3,522,358 0.6535 % 17 M ₹

Company contact information

Laurus Labs Ltd.

Serene Chambers, Road No. 7 2nd Floor

500034, Hyderabad

+91 40 3980 4333

http://www.lauruslabs.com
address Laurus Labs Limited(LAURUSLABS)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Laurus Labs Limited

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
450 INR
Average target price
383.4 INR
Spread / Average Target
-14.79%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
LAURUS LABS LIMITED Stock Laurus Labs Limited
+4.60% 2.91B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+34.00% 704B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.29% 577B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.75% 348B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.53% 327B
ABBVIE INC. Stock AbbVie Inc.
+4.95% 288B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.79% 234B
NOVARTIS AG Stock Novartis AG
+4.93% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-9.78% 194B
AMGEN INC. Stock Amgen Inc.
-4.89% 147B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. LAURUSLABS Stock
  4. Company Laurus Labs Limited